Switzerland
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 77.00 M
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
2 |
USD 12.41 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
3 |
USD -36.01 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
4 |
USD -56.78 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
5 |
USD -64.41 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
6 |
USD -73.62 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
7 |
USD -240.05 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Net Income is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 77.00 M.
The Vaccines company in Switzerland with the lowest Net Income is ADC Therapeutics SA (NYSE: ADCT) at USD -240.05 M.
The top 10 Vaccines companies in Switzerland by Net Income are Sandoz Group AG, Basilea Pharmaceutica AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, AC Immune SA, Molecular Partners AG and ADC Therapeutics SA.
The bottom 10 Vaccines companies in Switzerland by Net Income are ADC Therapeutics SA, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, Basilea Pharmaceutica AG and Sandoz Group AG.